We read the article by Garg et al,1 titled “Chondrocyte Viability in Human Nasal Septum After Morselization,” with great interest. Garg et al1 evaluated the viability of different degrees of human crushed septal cartilages by viability analysis of cartilages using a Live/Dead assay (Molecular Probes Inc, Eugene, Oregon) in conjunction with confocal microscopy within 12 hours of explantation. They performed different degrees of crushing with a Cottle Crusher (model 523900; Karl Storz GmbH & Co, Tuttlingen, Germany), as defined by our group2- 6: slightly crushed, 1 hit of moderate force to soften the surface without reducing cartilage elastic strength; moderately crushed, 2 moderate-force hits to soften the surface and also reduce elastic strength; significantly crushed, 3 to 4 moderate-force hits, enough to cause the graft bending with gravity; and severely crushed, 5 to 6 forceful hits to totally destroy the integrity of the cartilage. As Garg et al1 stated, their results supported the findings of our group's previous studies2- 6 that aggressive morselization had reduced chondrocyte viability. They also noted that the degree of crushing produced was dependent on the surgeon and the crushing product or device.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Facial Plastic Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.